x min read

Fantastic Four: Sarepta Therapeutics, Inc. (NASDAQ:SRPT), SM Energy Company (NYSE:SM), Gilead Sciences Inc. (NASDAQ:GILD),

Fantastic Four: Sarepta Therapeutics, Inc. (NASDAQ:SRPT), SM Energy Company (NYSE:SM), Gilead Sciences Inc. (NASDAQ:GILD),
Written by
Ryan Mitchell
Published on
November 13, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Trend Analysis reported that it has initiated dosing in a clinical study of eteplirsen for the treatment of Duchenne muscular dystrophy. The open-label study, 4658-204, will include 20 patients treated by means of eteplirsen who have genotypes amenable to exon 51 skipping and who meet other study inclusion criteria. Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) traded at $15.53 by plunging -0.45% with price volatility of 6.36% for a week and 7.53% for a month. Its beta stands at 0.56 times.SM Energy Company (NYSE:SM) Trend Analysis released that it has priced a private offering of $600M of 6.125 percent senior unsecured notes due 2022. The firm rose the size of the offering from the before released $400M to $600M. These senior notes will be issued at par. The Company aims to use the net proceeds from the offering to pay back outstanding borrowings under its credit facility and for general corporate purposes. SM Energy Company (NYSE:SM) stock has highest price of $54.27 in last session, beginning with a price of $52.83 and reported a loss of -1.53% to the closed at $52.75 with a day range of $52.55-$54.27. The stock is going forward its 52-week low with 3.01% and moving down from its 52 week high price with -43.80%.Gilead Sciences Inc. (NASDAQ:GILD) Trend Analysis released that the pricing of senior unsecured notes in an aggregate principal amount of $4B, in an underwritten, registered public offering, consisting of three tranches: $500 million of 2.350% senior notes maturing in February 2020, $1,750 million of 3.500% senior notes maturing in February 2025, $1,750 million of 4.500% senior notes maturing in February 2045. Gilead Sciences Inc. (NASDAQ:GILD) stock hit highest price at $107.81, beginning with a price of $107.55 and reported a loss of -1.03% to the closed at $106.90 with a day range of $105.70-$107.81. The total market capitalization remained 161.3 Billion, total volume of 12.76 Million shares held in the session was surprisingly higher than its average volume of 14989.41 shares.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.

Recommended for You